Pharmaceutical Headlines for June 8, 2011 ( Wednesday ).

Pharmaceutical Headlines for June 8, 2011 ( Wednesday ).

Pfizer Inc. (PFE) Seeks to Cut $1 Billion in Costs; Cuts are in Addition to Those Previously Announced in the Company's R&D Ops More...


Grifols' CEO Sees Few Cuts at Talecris Biotherapeutics (TLCR); Expects Layoffs to be Less Than 5% More...

PAREXEL International (PRXL) to Close Four Sites in Early Stage Cuts; Will Cut Bed Count By 28 Per Cent And Cause Around 300 Layoffs More...



Northeast Pharma Announces $370 Million Private Placement More...

Covidien (COV) Seeks Buyer for its Pharma Unit; Looking to Seek as Much as $4 Billion More...

Paladin Labs Inc. (CC:PLB) Seals $5.5M Cash and Equity Agreement for Somaxon Pharmaceuticals, Inc. (SOMX)'s Insomnia Drug More...

Biogen Idec, Inc. (Massachusetts) (BIIB) Seeking Deals to Expand Pipeline of MS Treatments More...

Moberg Derma Signs Distribution Agreement in Australia and New Zealand More...

Affectis Pharmaceuticals AG and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases More...

Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products More...

Actelion Ltd. (ALIOF.PK) Appoints COO in Management Shake-up, Creates Biotech Startup More...

TetraLogic Pharmaceuticals Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development More...

Ampio Pharmaceuticals, Inc. (AMPE) Appoints New Independent Director More...

Pennsylvania Bio Names Policy & Advocacy Director More...

China Pharmaceuticals (CFMID.OB) Announces Results for First Quarter 2011 More...

Eli Lilly and Company (LLY) to Settle Dispute Over Drug Copies More...

Abattis Clarifies Position on IP Acquisition from Former Zicam® DeveloperMore...

Merck & Co., Inc. (MRK) and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 More...

RXi Pharmaceuticals (RXII) Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at American Society of Clinical Oncology More...

Medicago, Inc. Reports Positive U.S. Clinical Trial Results for Its H1N1 / Seasonal Influenza Vaccine More...

Chroma Therapeutics and Cell Therapeutics, Inc. (CTIC) Announce New Positive Interim Phase II Data for Tosedostat in AML OPAL Study, Revealed at American Society of Clinical Oncology More...

Genta Incorporated (GETA.OB) Release: Tesetaxel Results From Multiple Dose-Ranging Clinical Trials Updated at American Society of Clinical Oncology More...

Almirall and GW Pharmaceuticals Release: Sativex(R) Approved in Denmark for the Treatment of Spasticity Due to Multiple Sclerosis (MS) More...

Incyte Corporation (INCY) Seeks Accelerated FDA Approval More...

FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer More...

• Coffee Drinking Improves Hepatitis C Treatment Response, Study Published in Gastroenterology More...

• Researchers Discover Biochemical Weakness of Malaria Parasite - Vaccine to be Developed, University of Copenhagen Study More...

• Older Age Does Not Cause Testosterone Levels to Decline in Healthy Men,University of Sydney Study More...

• Scots Patients Help to Pioneer New Treatment to 'Melt Away' Asthma,University Hospital of South Manchester Study More...

• Sex Supplement Improves Life of Cancer Survivors, Wake Forest University Baptist Medical Center Study More...

( Source: Biospace )
Tags: ,

About author

Make it happen !!

0 comments

Leave a Reply